Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism (Q34405999)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism (English)

1 reference

Europe PubMed Central

2 August 2017

Parkinson's disease

1 reference

based on heuristic

inferred from title

progressive supranuclear palsy

1 reference

based on heuristic

inferred from title

David R. Williams

object named as

David R Williams

1

0 references

Andrew John Lees

9

object named as

Andrew J Lees

1 reference

Europe PubMed Central

2 August 2017

2

object named as

Rohan de Silva

1 reference

Europe PubMed Central

2 August 2017

Dominic C Paviour

3

object named as

Dominic C Paviour

1 reference

Europe PubMed Central

2 August 2017

4

object named as

Alan Pittman

1 reference

Europe PubMed Central

2 August 2017

6

object named as

Linda Kilford

1 reference

Europe PubMed Central

2 August 2017

7

object named as

Janice L Holton

1 reference

Europe PubMed Central

2 August 2017

author name string

Hilary C Watt

5

1 reference

Europe PubMed Central

2 August 2017

Tamas Revesz

8

1 reference

Europe PubMed Central

2 August 2017

language of work or name

0 references

publication date

23 March 2005

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

128

1 reference

Europe PubMed Central

2 August 2017

Pt 6

1 reference

Europe PubMed Central

2 August 2017

1247-1258

1 reference

Europe PubMed Central

2 August 2017

The `subcortical dementia' of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Role of tau protein in both physiological and pathological conditions.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Association of an extended haplotype in the tau gene with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Progressive supranuclear palsy with dementia: cortical pathology.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Progressive supranuclear palsy diagnosis and confounding features: report on 16 autopsied cases

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Allocortical neurofibrillary changes in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Neurofilament monoclonal antibodies RT97 and 8D8 recognize different modified epitopes in paired helical filament-tau in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Comparative biochemistry of tau in progressive supranuclear palsy, corticobasal degeneration, FTDP-17 and Pick's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Overexpression of four-repeat tau mRNA isoforms in progressive supranuclear palsy but not in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Genetic evidence for the involvement of tau in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Atypical presentation of progressive supranuclear palsy.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Characterization of two pathological tau protein, variants in Alzheimer brain cortices.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Genotype-phenotype correlations in FTDP-17: does form follow function?

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Differential involvement and heterogeneous phosphorylation of tau isoforms in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Intraneuronal filamentous tau protein and alpha-synuclein deposits in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

New phosphorylation sites identified in hyperphosphorylated tau (paired helical filament-tau) from Alzheimer's disease brain using nanoelectrospray mass spectrometry

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The complex relationship between soluble and insoluble tau in tauopathies revealed by efficient dephosphorylation and specific antibodies.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer's disease and aging

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Progressive supranuclear palsy (subcortical argyrophilic dystrophy).

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Cognitive, neuroimaging, and pathological studies in a patient with Pick's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The clinical features and natural history of the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Autopsy patterns for Parkinson's disease and related disorders in Olmsted County, Minnesota.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Late onset dementia with argyrophilic grains and subcortical tangles or atypical progressive supranuclear palsy?

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Pure akinesia: an atypical manifestation of progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Glial localization of four-repeat tau in atypical progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

PHF-tau from Alzheimer's brain comprises four species on SDS-PAGE which can be mimicked by in vitro phosphorylation of human brain tau by glycogen synthase kinase-3 beta.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The selective vulnerability of brainstem nuclei to Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The structure of the tau haplotype in controls and in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The nucleus raphe interpositus in the Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy).

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Dopaminergic and cholinergic lesions in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Microtubule-associated protein tau gene: a risk factor in human neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

PROGRESSIVE SUPRANUCLEAR PALSY. A HETEROGENEOUS DEGENERATION INVOLVING THE BRAIN STEM, BASAL GANGLIA AND CEREBELLUM WITH VERTICAL GAZE AND PSEUDOBULBAR PALSY, NUCHAL DYSTONIA AND DEMENTIA.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Cholinergic vesicular transporters in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Expression patterns of tau mRNA isoforms correlate with susceptible lesions in progressive supranuclear palsy and corticobasal degeneration.

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

The significance of cortical pathology in progressive supranuclear palsy. Clinico-pathological data in 10 cases

1 reference

https://api.crossref.org/works/10.1093%2FBRAIN%2FAWH488

21 January 2018

Identifiers

10.1093/BRAIN/AWH488

1 reference

Europe PubMed Central

2 August 2017

1 reference

Europe PubMed Central

2 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34405999&oldid=1936273609"